US Patent 8362078 Method for reducing the severity of neurological disorders

The present invention relates to the use ofpolyunsaturated fatty acids andone or more components which have a beneficial effect on total methioninemetabolism selected from the group consisting of vitamin B12 and precursorsthereof, vitamin B6 and derivatives thereof, folic acid, zinc and magnesium,in the manufacture of a preparation for improving the action of receptors. This preparation is advantageously applied in patients suffering from Parkinson's disease, Huntington's chorea, epilepsy, schizophrenia, paranoia, depression, sleep disorders, impaired memory function, psychoses, dementia and ADHD.